190 related articles for article (PubMed ID: 16037277)
1. Oxidative stress and neurodegeneration.
Moreira PI; Smith MA; Zhu X; Nunomura A; Castellani RJ; Perry G
Ann N Y Acad Sci; 2005 Jun; 1043():545-52. PubMed ID: 16037277
[TBL] [Abstract][Full Text] [Related]
2. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease.
Dei R; Takeda A; Niwa H; Li M; Nakagomi Y; Watanabe M; Inagaki T; Washimi Y; Yasuda Y; Horie K; Miyata T; Sobue G
Acta Neuropathol; 2002 Aug; 104(2):113-22. PubMed ID: 12111353
[TBL] [Abstract][Full Text] [Related]
3. Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine.
Castellani RJ; Harris PL; Sayre LM; Fujii J; Taniguchi N; Vitek MP; Founds H; Atwood CS; Perry G; Smith MA
Free Radic Biol Med; 2001 Jul; 31(2):175-80. PubMed ID: 11440829
[TBL] [Abstract][Full Text] [Related]
4. Detection of N epsilon-(carboxymethyl)lysine (CML) and non-CML advanced glycation end-products in the anterior horn of amyotrophic lateral sclerosis spinal cord.
Kikuchi S; Shinpo K; Ogata A; Tsuji S; Takeuchi M; Makita Z; Tashiro K
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):63-8. PubMed ID: 12215227
[TBL] [Abstract][Full Text] [Related]
5. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS
Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202
[TBL] [Abstract][Full Text] [Related]
6. Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains.
Lüth HJ; Ogunlade V; Kuhla B; Kientsch-Engel R; Stahl P; Webster J; Arendt T; Münch G
Cereb Cortex; 2005 Feb; 15(2):211-20. PubMed ID: 15238435
[TBL] [Abstract][Full Text] [Related]
7. Immunochemical crossreactivity of antibodies specific for "advanced glycation endproducts" with "advanced lipoxidation endproducts".
Richter T; Münch G; Lüth HJ; Arendt T; Kientsch-Engel R; Stahl P; Fengler D; Kuhla B
Neurobiol Aging; 2005 Apr; 26(4):465-74. PubMed ID: 15653175
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons.
Horie K; Miyata T; Yasuda T; Takeda A; Yasuda Y; Maeda K; Sobue G; Kurokawa K
Biochem Biophys Res Commun; 1997 Jul; 236(2):327-32. PubMed ID: 9240434
[TBL] [Abstract][Full Text] [Related]
9. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
Abdul HM; Calabrese V; Calvani M; Butterfield DA
J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
[TBL] [Abstract][Full Text] [Related]
10. N epsilon-(carboxymethyl)lysine during the early development of hypertension.
Baumann M; Stehouwer C; Scheijen J; Heemann U; Struijker Boudier H; Schalkwijk C
Ann N Y Acad Sci; 2008 Apr; 1126():201-4. PubMed ID: 18079484
[TBL] [Abstract][Full Text] [Related]
11. Carnosine: a versatile antioxidant and antiglycating agent.
Reddy VP; Garrett MR; Perry G; Smith MA
Sci Aging Knowledge Environ; 2005 May; 2005(18):pe12. PubMed ID: 15872311
[TBL] [Abstract][Full Text] [Related]
12. epsilon-Glycation, APP and Abeta in ageing and Alzheimer disease: a hypothesis.
Schmitt HP
Med Hypotheses; 2006; 66(5):898-906. PubMed ID: 16442744
[TBL] [Abstract][Full Text] [Related]
13. The model Caenorhabditis elegans in diabetes mellitus and Alzheimer's disease.
Morcos M; Hutter H
J Alzheimers Dis; 2009; 16(4):897-908. PubMed ID: 19387121
[TBL] [Abstract][Full Text] [Related]
14. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.
Moreira PI; Santos MS; Seiça R; Oliveira CR
J Neurol Sci; 2007 Jun; 257(1-2):206-14. PubMed ID: 17316694
[TBL] [Abstract][Full Text] [Related]
15. Elevation of Nepsilon-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis.
Yagmur E; Tacke F; Weiss C; Lahme B; Manns MP; Kiefer P; Trautwein C; Gressner AM
Clin Biochem; 2006 Jan; 39(1):39-45. PubMed ID: 16321365
[TBL] [Abstract][Full Text] [Related]
16. Neuronal and glial advanced glycation end product [Nepsilon-(carboxymethyl)lysine]] in Alzheimer's disease brains.
Takeda A; Wakai M; Niwa H; Dei R; Yamamoto M; Li M; Goto Y; Yasuda T; Nakagomi Y; Watanabe M; Inagaki T; Yasuda Y; Miyata T; Sobue G
Acta Neuropathol; 2001 Jan; 101(1):27-35. PubMed ID: 11194938
[TBL] [Abstract][Full Text] [Related]
17. Environmental-induced oxidative stress in neurodegenerative disorders and aging.
Migliore L; Coppedè F
Mutat Res; 2009 Mar; 674(1-2):73-84. PubMed ID: 18952194
[TBL] [Abstract][Full Text] [Related]
18. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
19. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end products in human cancer tissues: detection of Nepsilon-(carboxymethyl)lysine and argpyrimidine.
van Heijst JW; Niessen HW; Hoekman K; Schalkwijk CG
Ann N Y Acad Sci; 2005 Jun; 1043():725-33. PubMed ID: 16037299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
